Eloxx Pharmaceuticals, Inc. (ELOX)
NCM · Healthcare · Biotechnology
$13.12
-1.35%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$53.0M
Shares Outstanding
4.0M
Exchange
NCM
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (1.2M) | (1.6M) | (3.8M) | (4.5M) |
| Net Income | (1.7M) | (1.9M) | (3.8M) | (4.5M) |
| Diluted EPS | $-4.95 | $-5.45 | $-0.88 | $-0.66 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 6.4M | 0.00 |
| Operating Income | (34.4M) | (17.3M) | (2.5M) | (6.4M) |
| Net Income | (36.1M) | (17.1M) | (3.1M) | (6.0M) |
| Diluted EPS | $-183.15 | $-72.93 | $-9.24 | $-5.39 |